Skip to main content
Erschienen in: Annals of Surgical Oncology 5/2011

01.05.2011 | Breast Oncology

Impact of Routine Cavity Shave Margins on Breast Cancer Re-excision Rates

verfasst von: Anne Kobbermann, MD, Alison Unzeitig, BS, Xian-Jin Xie, PhD, Jingsheng Yan, PhD, David Euhus, MD, Yan Peng, PhD, Venetia Sarode, MD, Amy Moldrem, MD, A. Marilyn Leitch, MD, Valerie Andrews, MD, Carrie Stallings, MD, Roshni Rao, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Breast-conserving therapy (BCT) is an accepted method of treating early breast cancer. We hypothesized that routine excision of additional cavity shave margins (CSM) at time of initial partial mastectomy reduces the need for additional surgery.

Methods

A single-institution retrospective review was performed of women, 18 years or older, with a new diagnosis of breast cancer who underwent partial mastectomy between 1 January 2004 and 1 October 2009. Five hundred thirty-three charts were reviewed. Of those, 69 patients underwent CSM at time of initial operation. These 69 patients were matched with patients who had undergone partial mastectomy without CSM by tumor size, presence of extensive intraductal component, and primary histology.

Results

The two groups were well matched for age, nuclear grade, associated lymphovascular invasion (LVI), receptor status, and multifocality. We found that 31.9% (44/138) required return to the operating room (OR) for re-excision of margins. Rate of return to the OR was 21.7% (15/69) in the CSM group and 42.0% (29/69) in the matched group (p = 0.011). Multivariate analysis found factors significantly associated with need for additional operation included lack of CSM (odds ratio 9.2, 95% CI 2.8–30.5, p = 0.0003), larger extent of intraductal component (odds ratio 7.0, 95% CI 1.8–27.0, p = 0.005), and lack of directed re-excision (odds ratio 6.4, 95% CI 1.7–25.1, p = 0.007).

Conclusions

CSM at time of initial partial mastectomy decreases rate of re-excision by as much as ninefold. CSM should be considered at time of initial operation to reduce the need for subsequent reoperation.
Literatur
1.
Zurück zum Zitat Morrow M, White J, Moughan J, et al. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol. 2001;19:2254–62.PubMed Morrow M, White J, Moughan J, et al. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol. 2001;19:2254–62.PubMed
2.
Zurück zum Zitat Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.PubMedCrossRef Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.PubMedCrossRef
3.
Zurück zum Zitat Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.PubMedCrossRef Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.PubMedCrossRef
4.
Zurück zum Zitat Camp ER, McAuliffe PF, Gilroy JS, et al. Minimizing local recurrence after breast conserving therapy using intraoperative shaved margins to determine pathologic tumor clearance. J Am Coll Surg. 2005;201:855–61.PubMedCrossRef Camp ER, McAuliffe PF, Gilroy JS, et al. Minimizing local recurrence after breast conserving therapy using intraoperative shaved margins to determine pathologic tumor clearance. J Am Coll Surg. 2005;201:855–61.PubMedCrossRef
5.
Zurück zum Zitat Blair SL, Thompson K, Rococco J, Malcarne V, Beitsch PD, Ollila DW. Attaining negative margins in breast-conservation operations: is there a consensus among breast surgeons? J Am Coll Surg. 2009;209:608–13.PubMedCrossRef Blair SL, Thompson K, Rococco J, Malcarne V, Beitsch PD, Ollila DW. Attaining negative margins in breast-conservation operations: is there a consensus among breast surgeons? J Am Coll Surg. 2009;209:608–13.PubMedCrossRef
6.
Zurück zum Zitat Sabel MS, Rogers K, Griffith K, et al. Residual disease after re-excision lumpectomy for close margins. J Surg Oncol. 2009;99:99–103.PubMedCrossRef Sabel MS, Rogers K, Griffith K, et al. Residual disease after re-excision lumpectomy for close margins. J Surg Oncol. 2009;99:99–103.PubMedCrossRef
7.
Zurück zum Zitat Wiley EL, Diaz LK, Badve S, Morrow M. Effect of time interval on residual disease in breast cancer. Am J Surg Pathol. 2003;27:194–8.PubMedCrossRef Wiley EL, Diaz LK, Badve S, Morrow M. Effect of time interval on residual disease in breast cancer. Am J Surg Pathol. 2003;27:194–8.PubMedCrossRef
8.
Zurück zum Zitat Gray RJ, Salud C, Nguyen K, et al. Randomized prospective evaluation of a novel technique for biopsy or lumpectomy of nonpalpable breast lesions: radioactive seed versus wire localization. Ann Surg Oncol. 2001;8:711–5.PubMedCrossRef Gray RJ, Salud C, Nguyen K, et al. Randomized prospective evaluation of a novel technique for biopsy or lumpectomy of nonpalpable breast lesions: radioactive seed versus wire localization. Ann Surg Oncol. 2001;8:711–5.PubMedCrossRef
9.
Zurück zum Zitat Rissanen TJ, Makarainen HP, Kiviniemi HO, Suramo, II. Ultrasonographically guided wire localization of nonpalpable breast lesions. J Ultrasound Med. 1994;13:183–8.PubMed Rissanen TJ, Makarainen HP, Kiviniemi HO, Suramo, II. Ultrasonographically guided wire localization of nonpalpable breast lesions. J Ultrasound Med. 1994;13:183–8.PubMed
10.
Zurück zum Zitat Rissanen TJ, Makarainen HP, Mattila SI, et al. Wire localized biopsy of breast lesions: a review of 425 cases found in screening or clinical mammography. Clin Radiol. 1993;47:14–22.PubMedCrossRef Rissanen TJ, Makarainen HP, Mattila SI, et al. Wire localized biopsy of breast lesions: a review of 425 cases found in screening or clinical mammography. Clin Radiol. 1993;47:14–22.PubMedCrossRef
11.
Zurück zum Zitat Gray RJ, Pockaj BA, Karstaedt PJ, Roarke MC. Radioactive seed localization of nonpalpable breast lesions is better than wire localization. Am J Surg. 2004;188:377–80.PubMedCrossRef Gray RJ, Pockaj BA, Karstaedt PJ, Roarke MC. Radioactive seed localization of nonpalpable breast lesions is better than wire localization. Am J Surg. 2004;188:377–80.PubMedCrossRef
12.
Zurück zum Zitat Thompson M, Henry-Tillman R, Margulies A, et al. Hematoma-directed ultrasound-guided (HUG) breast lumpectomy. Ann Surg Oncol. 2007;14:148–56.PubMedCrossRef Thompson M, Henry-Tillman R, Margulies A, et al. Hematoma-directed ultrasound-guided (HUG) breast lumpectomy. Ann Surg Oncol. 2007;14:148–56.PubMedCrossRef
13.
Zurück zum Zitat Smith LF, Henry-Tillman R, Harms S, et al. Hematoma-directed ultrasound-guided breast biopsy. Ann Surg. 2001;233:669–75.PubMedCrossRef Smith LF, Henry-Tillman R, Harms S, et al. Hematoma-directed ultrasound-guided breast biopsy. Ann Surg. 2001;233:669–75.PubMedCrossRef
14.
Zurück zum Zitat Kaufman CS, Jacobson L, Bachman B, Kaufman LB. Intraoperative ultrasonography guidance is accurate and efficient according to results in 100 breast cancer patients. Am J Surg. 2003;186: 378–82.PubMedCrossRef Kaufman CS, Jacobson L, Bachman B, Kaufman LB. Intraoperative ultrasonography guidance is accurate and efficient according to results in 100 breast cancer patients. Am J Surg. 2003;186: 378–82.PubMedCrossRef
15.
Zurück zum Zitat Smith LF, Rubio IT, Henry-Tillman R, Korourian S, Klimberg VS. Intraoperative ultrasound-guided breast biopsy. Am J Surg. 2000;180:419–23.PubMedCrossRef Smith LF, Rubio IT, Henry-Tillman R, Korourian S, Klimberg VS. Intraoperative ultrasound-guided breast biopsy. Am J Surg. 2000;180:419–23.PubMedCrossRef
16.
Zurück zum Zitat Rahusen FD, Bremers AJ, Fabry HF, van Amerongen AH, Boom RP, Meijer S. Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial. Ann Surg Oncol. 2002;9:994–8.PubMedCrossRef Rahusen FD, Bremers AJ, Fabry HF, van Amerongen AH, Boom RP, Meijer S. Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial. Ann Surg Oncol. 2002;9:994–8.PubMedCrossRef
17.
Zurück zum Zitat Ngo C, Pollet AG, Laperrelee J, Ackerman G, Gomme S, Thibault F, Fourchotte V, Salmon RJ. Intraoperative ultrasound localization of nonpalpable breast cancers. Ann Surg Oncol. 2007;14:2485–9.PubMedCrossRef Ngo C, Pollet AG, Laperrelee J, Ackerman G, Gomme S, Thibault F, Fourchotte V, Salmon RJ. Intraoperative ultrasound localization of nonpalpable breast cancers. Ann Surg Oncol. 2007;14:2485–9.PubMedCrossRef
18.
Zurück zum Zitat Jakub JW, Gray RJ, Degnim AC, Boughey JC, Gardner M, Cox CE. Current status of radioactive seed for localization of non palpable breast lesions. Am J Surg. 2010 April;199(4):522–8.PubMedCrossRef Jakub JW, Gray RJ, Degnim AC, Boughey JC, Gardner M, Cox CE. Current status of radioactive seed for localization of non palpable breast lesions. Am J Surg. 2010 April;199(4):522–8.PubMedCrossRef
19.
Zurück zum Zitat Rao R, Moldrem A, Sarode V, et al. Experience with seed localization for nonpalpable breast lesions in a public health care system. Ann Surg Oncol. 2010. doi:10.1245/s10434-010-1139-4. Rao R, Moldrem A, Sarode V, et al. Experience with seed localization for nonpalpable breast lesions in a public health care system. Ann Surg Oncol. 2010. doi:10.​1245/​s10434-010-1139-4.
20.
Zurück zum Zitat Lavoue V, Nos C, Clough KB, et al. Simplified technique of radioguided occult lesion localization (ROLL) plus sentinel lymph node biopsy (SNOLL) in breast carcinoma. Ann Surg Oncol. 2008;15:2556–61.PubMedCrossRef Lavoue V, Nos C, Clough KB, et al. Simplified technique of radioguided occult lesion localization (ROLL) plus sentinel lymph node biopsy (SNOLL) in breast carcinoma. Ann Surg Oncol. 2008;15:2556–61.PubMedCrossRef
21.
Zurück zum Zitat Monti S, Galimberti V, Trifiro G, et al. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology. Ann Surg Oncol. 2007;14:2928–31.PubMedCrossRef Monti S, Galimberti V, Trifiro G, et al. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology. Ann Surg Oncol. 2007;14:2928–31.PubMedCrossRef
22.
Zurück zum Zitat Intra M, de Cicco C, Gentilini O, Luini A, Paganelli G. Radioguided localisation (ROLL) of non-palpable breast lesions and simultaneous sentinel lymph node biopsy (SNOLL): the experience of the European Institute of Oncology. Eur J Nucl Med Mol Imaging. 2007;34:957–8.PubMedCrossRef Intra M, de Cicco C, Gentilini O, Luini A, Paganelli G. Radioguided localisation (ROLL) of non-palpable breast lesions and simultaneous sentinel lymph node biopsy (SNOLL): the experience of the European Institute of Oncology. Eur J Nucl Med Mol Imaging. 2007;34:957–8.PubMedCrossRef
23.
Zurück zum Zitat Young ES, Hogg DE, Krontiras H, et al. Specimen radiographs assist in identifying and assessing resection margins of occult breast carcinomas. Breast J. 2009;15:521–3.PubMedCrossRef Young ES, Hogg DE, Krontiras H, et al. Specimen radiographs assist in identifying and assessing resection margins of occult breast carcinomas. Breast J. 2009;15:521–3.PubMedCrossRef
24.
Zurück zum Zitat Mazouni C, Rouzier R, Balleyguier C, et al. Specimen radiography as predictor of resection margin status in non-palpable breast lesions. Clin Radiol. 2006;61:789–96.PubMedCrossRef Mazouni C, Rouzier R, Balleyguier C, et al. Specimen radiography as predictor of resection margin status in non-palpable breast lesions. Clin Radiol. 2006;61:789–96.PubMedCrossRef
25.
Zurück zum Zitat Cabioglu N, Hunt KK, Sahin AA, et al. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery. Ann Surg Oncol. 2007;14:1458–71.PubMedCrossRef Cabioglu N, Hunt KK, Sahin AA, et al. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery. Ann Surg Oncol. 2007;14:1458–71.PubMedCrossRef
26.
Zurück zum Zitat Ramanujam N, Brown J, Bydlon TM, et al. Quantitative spectral reflectance imaging device for intraoperative breast tumor margin assessment. Conf Proc IEEE Eng Med Biol Soc. 2009;1:6554–6. Ramanujam N, Brown J, Bydlon TM, et al. Quantitative spectral reflectance imaging device for intraoperative breast tumor margin assessment. Conf Proc IEEE Eng Med Biol Soc. 2009;1:6554–6.
27.
Zurück zum Zitat Gibson GR, Lesnikoski BA, Yoo J, Mott LA, Cady B, Barth RJ, Jr. A comparison of ink-directed and traditional whole-cavity re-excision for breast lumpectomy specimens with positive margins. Ann Surg Oncol. 2001;8:693–704.PubMedCrossRef Gibson GR, Lesnikoski BA, Yoo J, Mott LA, Cady B, Barth RJ, Jr. A comparison of ink-directed and traditional whole-cavity re-excision for breast lumpectomy specimens with positive margins. Ann Surg Oncol. 2001;8:693–704.PubMedCrossRef
28.
Zurück zum Zitat Jacobson AF, Asad J, Boolbol SK, Osborne MP, Boachie-Adjei K, Feldman SM. Do additional shaved margins at the time of lumpectomy eliminate the need for re-excision? Am J Surg. 2008;196:556–8.PubMedCrossRef Jacobson AF, Asad J, Boolbol SK, Osborne MP, Boachie-Adjei K, Feldman SM. Do additional shaved margins at the time of lumpectomy eliminate the need for re-excision? Am J Surg. 2008;196:556–8.PubMedCrossRef
29.
Zurück zum Zitat Hewes JC, Imkampe A, Haji A, Bates T. importance of routine cavity sampling in breast conservation surgery. Br J Surg. 2009;96:47–53.PubMedCrossRef Hewes JC, Imkampe A, Haji A, Bates T. importance of routine cavity sampling in breast conservation surgery. Br J Surg. 2009;96:47–53.PubMedCrossRef
30.
Zurück zum Zitat Tengher-Barna I, Hequet D, Reboul-Marty J, et al. Prevalence and predictive factors for the detection of carcinoma in cavity margin performed at the time of breast lumpectomy. Mod Pathol. 2009;22:299–305.PubMedCrossRef Tengher-Barna I, Hequet D, Reboul-Marty J, et al. Prevalence and predictive factors for the detection of carcinoma in cavity margin performed at the time of breast lumpectomy. Mod Pathol. 2009;22:299–305.PubMedCrossRef
31.
Zurück zum Zitat Janes SE, Stankhe M, Singh S, Isgar B. Systematic cavity shaves reduces close margins and re-excision rates in breast conserving surgery. Breast. 2006;15:326–30.PubMedCrossRef Janes SE, Stankhe M, Singh S, Isgar B. Systematic cavity shaves reduces close margins and re-excision rates in breast conserving surgery. Breast. 2006;15:326–30.PubMedCrossRef
32.
Zurück zum Zitat Marudanayagam R, Singhal R, Tanchel B, O’Connor B, Balasubramanian B, Paterson I. Effect of cavity shaving on reoperation rate following breast-conserving surgery. Breast J. 2008;14:570–3.PubMedCrossRef Marudanayagam R, Singhal R, Tanchel B, O’Connor B, Balasubramanian B, Paterson I. Effect of cavity shaving on reoperation rate following breast-conserving surgery. Breast J. 2008;14:570–3.PubMedCrossRef
33.
Zurück zum Zitat Singletary SE. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg. 2002;184(5):383–93.PubMedCrossRef Singletary SE. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg. 2002;184(5):383–93.PubMedCrossRef
34.
Zurück zum Zitat Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–106. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–106.
35.
Zurück zum Zitat Fisher B, Bauer M, Margolese R et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. NEJM. 1985;312:665–73.PubMedCrossRef Fisher B, Bauer M, Margolese R et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. NEJM. 1985;312:665–73.PubMedCrossRef
36.
Zurück zum Zitat Lester SC, Bose S, Yunn-Yi C, et al. Protocol for the examination of specimens from patients with invasive carcinoma of the breast. Arch Pathol Lab Med. 2009 Oct;133(10):1515–38.PubMed Lester SC, Bose S, Yunn-Yi C, et al. Protocol for the examination of specimens from patients with invasive carcinoma of the breast. Arch Pathol Lab Med. 2009 Oct;133(10):1515–38.PubMed
37.
Zurück zum Zitat Molina MA, Snell S, Franceschi D et al. Breast specimen orientation. Ann Surg Oncol. 2009;16:285–8.PubMedCrossRef Molina MA, Snell S, Franceschi D et al. Breast specimen orientation. Ann Surg Oncol. 2009;16:285–8.PubMedCrossRef
38.
Zurück zum Zitat Cao D, Lin C, Woo S, Vang R, Tsangaris TN, Argani P. Separate cavity margin sampling at the time of initial breast lumpectomy significantly reduces the need for reexcisions. Am J Surg Pathol. 2005;29:1625–32.PubMedCrossRef Cao D, Lin C, Woo S, Vang R, Tsangaris TN, Argani P. Separate cavity margin sampling at the time of initial breast lumpectomy significantly reduces the need for reexcisions. Am J Surg Pathol. 2005;29:1625–32.PubMedCrossRef
39.
Zurück zum Zitat Rizzo M, Iyengar R, Gabram SGA, Park J, Birdsong G, Chandler KL, Mosunjac MB. The effects of additional tumor cavity sampling at the time of breast-conserving surgery on final margin status, volume of resection, and pathologist workload. Ann Surg Oncol. 2010;17:228–34.PubMedCrossRef Rizzo M, Iyengar R, Gabram SGA, Park J, Birdsong G, Chandler KL, Mosunjac MB. The effects of additional tumor cavity sampling at the time of breast-conserving surgery on final margin status, volume of resection, and pathologist workload. Ann Surg Oncol. 2010;17:228–34.PubMedCrossRef
Metadaten
Titel
Impact of Routine Cavity Shave Margins on Breast Cancer Re-excision Rates
verfasst von
Anne Kobbermann, MD
Alison Unzeitig, BS
Xian-Jin Xie, PhD
Jingsheng Yan, PhD
David Euhus, MD
Yan Peng, PhD
Venetia Sarode, MD
Amy Moldrem, MD
A. Marilyn Leitch, MD
Valerie Andrews, MD
Carrie Stallings, MD
Roshni Rao, MD
Publikationsdatum
01.05.2011
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 5/2011
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1420-6

Weitere Artikel der Ausgabe 5/2011

Annals of Surgical Oncology 5/2011 Zur Ausgabe

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Recycling im OP – möglich, aber teuer

05.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Im OP der Zukunft läuft nichts mehr ohne Kollege Roboter

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.